CTI BioPharma
CTIC
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)
Categories
CTI BioPharma (CTIC) - Cash on Hand
Cash on Hand as of March 2023 : $59.01 M
According to CTI BioPharma
's latest financial reports the company has $59.01 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
CTI BioPharma - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $79.93 M | 22.14% |
| 2021-12-31 | $65.44 M | 24.78% |
| 2020-12-31 | $52.45 M | 55.8% |
| 2019-12-31 | $33.66 M | -49.78% |
| 2018-12-31 | $67.03 M | 55.12% |
| 2017-12-31 | $43.21 M | -1.78% |
| 2016-12-31 | $44 M | -65.67% |
| 2015-12-31 | $0.12 B | 80.71% |
| 2014-12-31 | $70.93 M | -0.99% |
| 2013-12-31 | $71.63 M | 42.04% |
| 2012-12-31 | $50.43 M | 7.19% |
| 2011-12-31 | $47.05 M | 107.74% |
| 2010-12-31 | $22.64 M | -40.1% |
| 2009-12-31 | $37.81 M | 254.33% |
| 2008-12-31 | $10.67 M | -41.83% |
| 2007-12-31 | $18.34 M | -65.92% |
| 2006-12-31 | $53.83 M | -21.84% |
| 2005-12-31 | $68.88 M | -40.56% |
| 2004-12-31 | $0.11 B | 26.52% |
| 2003-12-31 | $91.58 M | -34.7% |
| 2002-12-31 | $0.14 B | -45.2% |
| 2001-12-31 | $0.25 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 23,560.00% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $2.92 B | 4,861.28% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 18,445.69% | 🇺🇸 USA |
 Baxter BAX | $3.19 B | 5,312.55% | 🇺🇸 USA |
 Incyte INCY | $3.65 B | 6,095.52% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 20,709.68% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 5,366.78% | 🇮🇱 Israel |